New research on benefits of Magtein® in collegiate athletes spotlighted at SupplySide Global

Credit: PeopleImages/Shutterstock

CITY OF INDUSTRY, Calif. — ThreoTech, LLC, the exclusive global supplier of Magtein®, today announced that new findings on Magtein in collegiate athletes will be spotlighted at SupplySide Global on Wednesday, October 28, 2026, from 9:00–10:00 AM PST.

The breakfast briefing, "Magnesium L-Threonate (Magtein®) in Collegiate Athletes: Lessons from the UCLA Sports Medicine Study," will be led by Dr. Jeremy Swisher, MD, UCLA Health Sciences Assistant Clinical Professor and sports medicine physician.

Magtein is the patented, proprietary form of magnesium that supports healthy magnesium levels in the brain by facilitating magnesium delivery across the blood–brain barrier and into brain neurons, helping maintain optimal magnesium availability where it is needed.

To date, five peer-reviewed, randomized, double-blind, placebo-controlled human trials (RCTs) on Magtein have been published across three countries: the United States, China, and Australia. These results have demonstrated improvements in brain health, cognitive vitality, and sleep quality across diverse adult populations. Additional human RCTs are underway, including studies conducted by independent research groups, further expanding the clinical evidence base for Magtein.

As the Magtein research base has grown, it has become an increasingly trusted magnesium form for studying brain magnesium, cognition, and healthy brain function across both preclinical and human research, with the evidence base now spanning more than 50 peer-reviewed scientific publications.

Now researchers have carried out the first study specifically exploring Magtein’s benefits in athletes. This randomized, placebo-controlled study in UCLA college athletes examined whether the sleep benefits previously demonstrated with Magtein extend to an athletic population, while also assessing recovery and physical performance over four weeks.

At SupplySide Global, ThreoTech – the commercial team behind Magtein – will hold a breakfast briefing to discuss the research recently carried out by Dr. Swisher's group at UCLA. These preliminary findings were first presented as a poster at the American Medical Society for Sports Medicine (AMSSM) Annual Meeting in April 2026, and full results are scheduled to be published in a peer-reviewed journal later this year.

Dr. Jeremy Swisher, MD, Health Sciences Assistant Clinical Professor at UCLA, is the Principal Investigator of the study. Dr. Swisher specializes in the care of student athletes and is the head team physician for UCLA Women's Volleyball and Swim & Dive. He has provided medical coverage for the LA Lakers, LA Dodgers, and LA Sparks.

Dr. Rafea Naffa, Director of R&D at ThreoTech, said: “We’ve always been interested in Magtein’s potential in sports nutrition, and we're delighted that new research is now specifically examining Magtein's benefits in athletes. We’re particularly excited that this work is independently coming out of UCLA, and we’re looking forward to welcoming Dr. Swisher to SupplySide Global.”

ThreoTech will be exhibiting at SupplySide Global, Booth #5652.

About Magtein

Magtein® is the patented form of magnesium L-threonate, developed by researchers in 2010 to help address the challenge of supporting magnesium levels in the brain. Five peer-reviewed, randomized, double-blind, placebo-controlled human trials have examined Magtein, with multiple studies reporting improvements in cognitive function, sleep quality, and many other benefits.* Today, Magtein is used in over 500 products by partner brands globally and continues to be clinically studied. Magtein is stable, tasteless, odorless, colorless, and water-soluble, with applicability across capsules, tablets, gels, powders, and liquids.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

About ThreoTech, LLC

ThreoTech, LLC is an innovative manufacturing, marketing, and research company created to promote the power of Magtein. ThreoTech, LLC is the exclusive global ingredient supplier and patent licensee for Magtein, ensuring its quality and authenticity.

Media Contact

Angela Kelly, Sr. Manager, Marketing & Communications
a.kelly@threotech.com

Credit PeopleImages Shutterstock.com.jpg

JPEG 2.8 MB

Threotech SSG 26 PR.docx

DOCX 203 KB

Threotech SSG 26 PR.pdf

PDF 265 KB

 

 

Share

Get updates in your mailbox

By clicking "Subscribe" I confirm I have read and agree to the Privacy Policy.

About Magtein

For media enquiries, please contact:
Richard Clarke, Ingredient Communications | richard@ingredientcommunications.com

About ThreoTech
ThreoTech, LLC is an innovative manufacturing, marketing, and research company that was created as a spinoff from AIDP to promote the power of Magtein®. ThreoTech is the exclusive global ingredient supplier and patent licensee for Magtein®, ensuring its quality and authenticity.  

About Magtein®
Magtein® is a branded magnesium L-threonate. For more information, please visit www.magtein.com   

About AIDP
AIDP is a North American ingredient supplier serving the dietary supplement, food, beverage, and pet food industries, and the original company to bring Magtein® to the market. AIDP specializes in branded ingredients and now has over 40 IP protected products along with a portfolio of over 300 commodity products.